MMedication Read More US Health Spending Set to Exceed $6 Trillion in 2026 on Prescription Drug SurgeJune 25, 2026 The US is expected to spend more than $560 billion on prescription medications in 2026, up 8.2% from…
HHealthcare Read More Lilly gets rare downgrade as analysts question hype over GLP-1 pills and Zepbound’s cash salesMarch 18, 2026 Last Updated: March 17, 2026 at 6:27 p.m. ETFirst Published: March 17, 2026 at 2:28 p.m. ET In a surprising…
MMedication Read More Taking the new Wegovy pill every day is really complicated. Will patients stick with it?February 11, 2026 Published: Feb. 10, 2026 at 3:48 p.m. ET Patients are thrilled that there’s finally a GLP-1 pill, but swallowing…
MMedication Read More Half of GLP-1 users ditch their injections — and some are turning to other weight-loss methods instead – MarketWatchJanuary 17, 2026 Half of GLP-1 users ditch their injections — and some are turning to other weight-loss methods instead MarketWatchThe Truth…
HHealthcare Read More Obesity, M&A, Biotech Resurgence: A 2026 Guide to Health StocksJanuary 10, 2026 The health-care corner of the US equity market has traditionally been viewed as defensive, thanks to steady growth…
HHealthcare Read More Trump’s Wegovy and Zepbound Drug Price Deal Is Short on DetailsNovember 10, 2025 A White House deal with Eli Lilly & Co. and Novo Nordisk to lower the prices of their…
SScience Read More How Voyaging to Mars Risks Harming an Astronaut’s Eyes – Bloomberg.comNovember 7, 2025 How Voyaging to Mars Risks Harming an Astronaut’s Eyes Bloomberg.comMen and women’s eyes respond differently to spaceflight Earth.comSpaceflight alters brain…
MMedication Read More Metsera Weight-Loss Drug Shows ‘Excellent’ Tolerability in StudyNovember 6, 2025 Metsera Inc.’s next-generation weight-loss drug showed good tolerability with few participants dropping out of a mid-stage trial, adding…
HHealthcare Read More Lilly, Novo to Lower Obesity Drug Prices in Deal with TrumpNovember 6, 2025 Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for…
HHealthcare Read More Lilly and Novo Rise on Report of Deal for Medicare CoverageNovember 4, 2025 Shares of Eli Lilly & Co and Novo Nordisk A/S rose on a report that the companies were…
HHealthcare Read More Lilly Makes Billions of Weight-Loss Pills Before US ApprovalOctober 28, 2025 Eli Lilly & Co. has already produced billions of doses of its next-generation weight-loss pill, anticipating massive global…
HHealthcare Read More Novo (NVO) Plans to Make Obesity Pill Available Online Once ApprovedOctober 10, 2025 Novo Nordisk A/S plans to launch its new obesity pill on telehealth sites like Ro and WeightWatchers as…